Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease | Zendy

Luca De Nicola | Zendy; Giuseppe Conte | Zendy; Paolo Chiodini | Zendy; Bruno Cianciaruso | Zendy; Andrea Pota | Zendy; Vincenzo Bellizzi | Zendy; Giuseppina Tirino | Zendy; D Avino | Zendy; Fausta Catapano | Zendy; Roberto Minutolo | Zendy

Open Access

Stability of Target Hemoglobin Levels during the First Year of Epoetin Treatment in Patients with Chronic Kidney Disease

Author(s) -

Luca De Nicola,

Giuseppe Conte,

Paolo Chiodini,

Bruno Cianciaruso,

Andrea Pota,

Vincenzo Bellizzi,

Giuseppina Tirino,

D Avino,

Fausta Catapano,

Roberto Minutolo

Publication year - 2007

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.01690407

Subject(s) - medicine , hemoglobin , kidney disease , hemodialysis , dialysis , anemia , gastroenterology , erythropoietin , urology , epoetin alfa , peritoneal dialysis , renal function , proportional hazards model

Instability of hemoglobin levels during epoetin therapy is a new problem in hemodialysis. We evaluated extent and correlates of time in target, that is, the time spent with hemoglobin > or = 11 g/dl during the first year of epoetin and its association with renal survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research